{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:28:40Z","timestamp":1787023720244,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10067-026-08231-7","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:02:55Z","timestamp":1782464575000},"page":"5085-5091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics of lung cancer in patients with connective tissue disease associated interstitial lung disease: a brief report"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4712-4740","authenticated-orcid":false,"given":"Guohua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6460-221X","authenticated-orcid":false,"given":"Yuhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"8231_CR1","doi-asserted-by":"publisher","first-page":"220210","DOI":"10.1183\/16000617.0210-2022","volume":"32","author":"GM Joy","year":"2023","unstructured":"Joy GM, Arbiv OA, Wong CK et al (2023) Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis. Eur Respir Rev 32:220210. https:\/\/doi.org\/10.1183\/16000617.0210-2022","journal-title":"Eur Respir Rev"},{"key":"8231_CR2","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-2600(25)00129-8","volume":"13","author":"P Spagnolo","year":"2025","unstructured":"Spagnolo P, Guler SA, Chaudhuri N et al (2025) Global epidemiology and burden of interstitial lung disease. Lancet Respir Med 13:739\u2013755. https:\/\/doi.org\/10.1016\/S2213-2600(25)00129-8","journal-title":"Lancet Respir Med"},{"key":"8231_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12931-019-1094-y","volume":"20","author":"WI Choi","year":"2019","unstructured":"Choi WI, Lee DY, Choi HG et al (2019) Lung cancer development and mortality in interstitial lung disease with and without connective tissue diseases: a five-year nationwide population based study. Respir Res 20:117. https:\/\/doi.org\/10.1186\/s12931-019-1094-y","journal-title":"Respir Res"},{"key":"8231_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.resinv.2016.11.003","volume":"55","author":"A Saijo","year":"2017","unstructured":"Saijo A, Hanibuchi M, Goto H et al (2017) An analysis of the clinical features of lung cancer in patients with connective tissue diseases. Respir Investig 55:153\u2013160. https:\/\/doi.org\/10.1016\/j.resinv.2016.11.003","journal-title":"Respir Investig"},{"key":"8231_CR5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.rmed.2007.10.022","volume":"102","author":"TN Adzic","year":"2008","unstructured":"Adzic TN, Pesut DP, Nagorni-Obradovic LM et al (2008) Clinical features of lung cancer in patients with connective tissue diseases: a 10-year hospital based study. Respir Med 102:620\u2013624. https:\/\/doi.org\/10.1016\/j.rmed.2007.10.022","journal-title":"Respir Med"},{"key":"8231_CR6","doi-asserted-by":"publisher","first-page":"e5716","DOI":"10.1097\/MD.0000000000005716","volume":"95","author":"Y Enomoto","year":"2016","unstructured":"Enomoto Y, Inui N, Yoshimura K et al (2016) Lung cancer development in patients with connective tissue disease related interstitial lung disease: a retrospective observational study. Medicine (Baltimore) 95:e5716. https:\/\/doi.org\/10.1097\/MD.0000000000005716","journal-title":"Medicine (Baltimore)"},{"key":"8231_CR7","doi-asserted-by":"publisher","first-page":"799","DOI":"10.21037\/jtd.2017.12.134","volume":"10","author":"S Watanabe","year":"2018","unstructured":"Watanabe S, Saeki K, Waseda Y et al (2018) Lung cancer in connective tissue disease-associated interstitial lung disease: clinical features and impact on Outcomes. J Thorac Dis 10:799\u2013807. https:\/\/doi.org\/10.21037\/jtd.2017.12.134","journal-title":"J Thorac Dis"},{"key":"8231_CR8","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860\u2013867. https:\/\/doi.org\/10.1038\/nature01322","journal-title":"Nature"},{"key":"8231_CR9","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.3390\/jcm14145160","volume":"14","author":"N Lizuka","year":"2025","unstructured":"Lizuka N, Hoshida Y, Miyamoto AT et al (2025) Immunosuppressants\/Immunomodulators and Malignancy. J Clin Med 14:5160. https:\/\/doi.org\/10.3390\/jcm14145160","journal-title":"J Clin Med"},{"key":"8231_CR10","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388:2023\u20132038. https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8","journal-title":"Lancet"},{"key":"8231_CR11","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202006020","volume":"172","author":"M Kiriakidou","year":"2020","unstructured":"Kiriakidou M, Ching CL (2020) Systemic lupus erythematosus. Ann Intern Med 172:ITC81\u2013ITC96. https:\/\/doi.org\/10.7326\/AITC202006020","journal-title":"Ann Intern Med"},{"key":"8231_CR12","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390:1685\u20131699. https:\/\/doi.org\/10.1016\/S0140-6736(17)30933-9","journal-title":"Lancet"},{"key":"8231_CR13","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zeron","year":"2016","unstructured":"Brito-Zeron P, Baldini C, Bootsma H et al (2016) Sjogren syndrome. Nat Rev Dis Primers 2:16047. https:\/\/doi.org\/10.1038\/nrdp.2016.47","journal-title":"Nat Rev Dis Primers"},{"key":"8231_CR14","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/rheumatology\/kex226","volume":"56","author":"LG Rider","year":"2017","unstructured":"Rider LG, Ruperto N, Pistorio A et al (2017) 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects. Rheumatology (Oxford) 56:1884\u20131893. https:\/\/doi.org\/10.1093\/rheumatology\/kex226","journal-title":"Rheumatology (Oxford)"},{"key":"8231_CR15","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1556\/OH.2013.29704","volume":"154","author":"M Zeher","year":"2013","unstructured":"Zeher M (2013) Vasculitis 2013. What are the changes introduced in the 2012 chapel hill consensus conference. Orv Hetil 154:1571\u20131578. https:\/\/doi.org\/10.1556\/OH.2013.29704","journal-title":"Orv Hetil"},{"key":"8231_CR16","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.berh.2007.09.004","volume":"21","author":"M Mosca","year":"2007","unstructured":"Mosca M, Tani C, Bombardieri S (2007) Undifferentiated connective tissue diseases: a new frontier for rheumatology. Best Pract Res Clin Rheumatol 21:1011\u20131023. https:\/\/doi.org\/10.1016\/j.berh.2007.09.004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8231_CR17","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL et al (2018) Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 198:e44\u2013e68. https:\/\/doi.org\/10.1164\/rccm.201807-1255ST","journal-title":"Am J Respir Crit Care Med"},{"key":"8231_CR18","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1378\/chest.12-0741","volume":"143","author":"R Vij","year":"2013","unstructured":"Vij R, Strek ME (2013) Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest 143:814\u2013824. https:\/\/doi.org\/10.1378\/chest.12-0741","journal-title":"Chest"},{"key":"8231_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/J.JCM.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155\u2013163. https:\/\/doi.org\/10.1016\/J.JCM.2016.02.012","journal-title":"J Chiropr Med"},{"key":"8231_CR20","doi-asserted-by":"publisher","first-page":"175346662110170","DOI":"10.1177\/17534666211017050","volume":"15","author":"Q Chen","year":"2021","unstructured":"Chen Q, Liu P, Zhou H et al (2021) An increased risk of lung cancer in combined pulmonary fibrosis and emphysema patients with usual interstitial pneumonia compared with patients with idiopathic pulmonary fibrosis alone: a systematic review and meta-analysis. Ther Adv Respir Dis 15:17534666211017050. https:\/\/doi.org\/10.1177\/17534666211017050","journal-title":"Ther Adv Respir Dis"},{"key":"8231_CR21","doi-asserted-by":"publisher","first-page":"9476","DOI":"10.3390\/ijms26199476","volume":"26","author":"VAF Bastos","year":"2025","unstructured":"Bastos VAF, Souza AG, Guedes VCS et al (2025) Shared and context-specific mechanisms of EMT and cellular plasticity in cancer and fibrotic diseases. Int J Mol Sci 26:9476. https:\/\/doi.org\/10.3390\/ijms26199476","journal-title":"Int J Mol Sci"},{"key":"8231_CR22","doi-asserted-by":"publisher","first-page":"103501","DOI":"10.1016\/j.jtho.2025.10.008","volume":"21","author":"I Odintsov","year":"2025","unstructured":"Odintsov I, Hammer MM, Ricciuti B et al (2025) The genomic landscape of NSCLC in systemic sclerosis reveals frequent TP53 mutations and a paucity of actionable oncogenes. J Thorac Oncol 21:103501. https:\/\/doi.org\/10.1016\/j.jtho.2025.10.008","journal-title":"J Thorac Oncol"},{"key":"8231_CR23","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.18632\/oncotarget.13947","volume":"8","author":"WP Wang","year":"2017","unstructured":"Wang WP, Sun Y, Lu Q et al (2017) Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6\/ STAT3 and TGF-\u03b2\/SMAD3 signaling pathway. Oncotarget 8:5909\u20135923. https:\/\/doi.org\/10.18632\/oncotarget.13947","journal-title":"Oncotarget"},{"key":"8231_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s40001-023-01384-0","volume":"28","author":"CX Ma","year":"2023","unstructured":"Ma CX, Meng KF, Shi SY et al (2023) Clinical significance of interleukin-6, total bilirubin, CD3 + CD4 + T cells counts in the acute exacerbation of connective tissue disease-associated interstitial lung disease: a cross-sectional study. Eur J Med Res 28:393. https:\/\/doi.org\/10.1186\/s40001-023-01384-0","journal-title":"Eur J Med Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08231-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08231-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08231-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:17:28Z","timestamp":1787023048000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08231-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["8231"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08231-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Ethics Committee of Beijing Shijitan Hospital, Capital Medical University (sjtkyll-jy-2023(006)), and the requirement for obtaining written informed consent from patients was waived.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}